CapyFin

Calendar Reports

Search for a symbol...

Loading...

CapyFin Real-time Earnings Reports.

Products

Earnings
API

Get in Touch

Contact Us
X (Twitter)
LinkedIn

Resources

Privacy Policy
Terms of Service
Sign Up
Sign In

© 2026 CapyFin. All rights reserved.

Disclaimer: CapyFin provides financial data and AI analysis for informational purposes only and does not provide investment advice or recommendations. Real-time data and AI outputs may be inaccurate, incomplete, delayed, or contain errors or hallucinations. Investing involves risk, including loss of principal. The service is provided “as is” and we disclaim liability to the fullest extent permitted by law. See our Terms of Service and Privacy Policy.

Catalyst Pharmaceuticals Fiscal Q3 2024 Earnings Report - CapyFin

Catalyst Pharmaceuticals

CPRX · NASDAQ🇺🇸

Overview Earnings

Dividends Seasonality Metrics

Q3 2025 -1.87%Q2 2025 -10.13%Q1 2025 -3.02%Q4 2024 +5.25%Q3 2024 +5.87%Q2 2024 +13.03%Q1 2024 +3.37%Q4 2023 +11.71%Q3 2023 -4.12%Q2 2023 +4.82%Q1 2023 -18.68%Q4 2022 +6.06%Q3 2022 +0.65%Q2 2022 +20.79%Q1 2022 -0.46%Q4 2021 -1.99%Q3 2021 +2.71%Q2 2021 +2.24%Q1 2021 -1.86%Q4 2020 +6.68%Q3 2020 +7.94%Q2 2020 -17.53%Q1 2020 -5.66%Q4 2019 -15.25%Q3 2019 -9.56%Q2 2019 +0.59%Q1 2019 -0.32%Q4 2018 +16.78%Q3 2018 -4.94%Q2 2018 +2.45%Q1 2018 +0.73%Q4 2017 -9.58%Q3 2017 -4.17%Q2 2017 -1.38%Q1 2017 +2.22%Q4 2016 +29.06%Q3 2016 +3.96%Q2 2016 -1.30%Q1 2016 -6.29%Q4 2015 -10.57%Q3 2015 -5.28%Q2 2015 -9.23%Q1 2015 -1.46%Q4 2014 +15.79%Q3 2014 -6.34%Q2 2014 -2.67%Q1 2014 +2.82%Q4 2013 +9.63%Q3 2013 -2.08%Q2 2013 -6.29%Q1 2013 -7.33%Q4 2012 -5.14%Q3 2012 -10.68%Q2 2012 -7.89%Q1 2012 -5.56%Q4 2011 -6.14%Q3 2011 +2.02%Q2 2011 -6.62%Q1 2011 -0.68%Q4 2010 -0.01%Q3 2010 -0.55%Q2 2010 +0.30%Q1 2010 -9.85%

Nov 06, 2024

•

Sep 30, 2024

Catalyst Pharmaceuticals Q3 2024 Earnings Report

Previous year: $103M

Previous year: $0.49

Cost of Sales Growth YoY

R&D Expenses Growth YoY

SG&A Expenses Growth YoY

Previous year: $80M

Cash and Equivalents

Previous year: $121M

Previous year: $45.1M

Previous year: $413M

Catalyst Pharmaceuticals

Unlock previous datapoints

Catalyst Pharmaceuticals

Unlock previous datapoints

Revenue by Segment

FIRDAPSE Product Revenue, Net Revenue

CapyFin.com

AGAMREE Product Revenue, Net Revenue

CapyFin.com

FYCOMPA Product Revenue, Net Revenue

CapyFin.com

Revenue & Expenses

Visualization of income flow from segment revenue to net income

Historical Earnings Impact

Analyze how earnings announcements historically affect stock price performance

Avg. Return Before/After Earnings

Loading earnings performance data...

Loading earnings reaction data...

Company Overview

Full financial data and analysis

View Catalyst Pharmaceuticals

Catalyst Pharmaceuticals Revenue by Segment